Dengue Tetravalent Vaccine (Live, Attenuated) Takeda

Dengue Tetravalent Vaccine (Live, Attenuated) by Takeda is designed to protect against dengue fever. This vaccine targets all four dengue virus serotypes, offering broad coverage. Learn more about its uses and benefits.

The Dengue Tetravalent Vaccine is intended for the prevention of dengue fever, a mosquito-borne viral infection. It is administered to individuals who are at risk of exposure to the dengue virus. The vaccine works by stimulating the immune system to produce a protective response against all four serotypes of the virus.

Common effects of the Dengue Tetravalent Vaccine may include mild fever, headache, and injection site reactions such as pain or swelling. These effects are typically mild and short-lived, indicating that the body is responding to the vaccine.

It is important to inform your healthcare provider about any allergies or medical conditions before receiving the Dengue Tetravalent Vaccine. The vaccine should be administered by a healthcare professional and stored according to specific temperature guidelines to maintain its effectiveness.

The Dengue Tetravalent Vaccine may interact with other medications or vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving this vaccine. Additionally, avoid alcohol and certain medications that may weaken the immune system.